Fresh analysis indicates that individuals who come off blockbuster weight-loss injections like semaglutide or tirzepatide may regain shed pounds much more quickly than those who halt conventional diet and exercise programs.
Published data in a major health publication demonstrates that while obese people often shed substantial amounts of their total mass while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month after stopping.
"People buying such treatments need to be informed of the danger of fast rebound weight gain when the medication concludes," cautioned researcher Dr. Susan Jebb.
This pace of regain implies a reversion to pre-treatment mass within about 18 months.
Comparing Therapies
The research, which looked at dozens of trials involving over 9,000 of patients, contrasted the results of GLP-1 agonists with other pills.
Scientists point out that people who lose weight through lifestyle changes alone generally experience a more gradual creep back—around 0.1 kg a month—after stopping.
The Reason for the Fast Rebound
Experts believe the mechanism of the jabs accounts for the amplified rebound.
GLP-1 drugs mimic a body's own chemical called GLP-1, which helps regulate feelings of fullness.
"Long-term administration of the hormone concentrations far above than normal may cause the body to produce less of its own natural hormone, and could reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.
"Stopping of this GLP-1 'fix' leads to appetite is unsuppressed, making binge eating far more likely."
A Lifelong Condition?
The NHS recommend the injections for people with obesity-related health risks, alongside prescribed diet and exercise modifications.
Professionals argue that, given the significant potential of relapse, the treatment might need to be ongoing.
This perspective is supported by drug manufacturers, who say that the results "emphasize the chronic character of obesity," akin to managing conditions like diabetes.
Patient Experiences
People who have stopped the jabs report a powerful resurgence of appetite.
"It was like something flipping and I was suddenly starving," described an individual.
This difficulty is exacerbated if individuals have not established lasting dietary or behavioural changes during therapy.
Growing Interest
Survey data suggest that millions of adults in the UK have used these injections in the last 12 months, with interest being substantial.
- Adoption is higher among women compared to males.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion obtain the medications through private healthcare rather than the NHS.
Finally, experts stress that while the jabs are powerful tools for weight loss, they are not a magic cure and lasting health benefits hinges on integrated lifestyle support.
